Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D012436 |
S-Adenosylmethionine |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of UBD mRNA] | decreases reaction|increases expression | 18098314
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of UBD protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of UBD mRNA | affects expression | 16483693
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBD mRNA | affects cotreatment|increases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of UBD mRNA | increases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of UBD mRNA | decreases expression | 20127859
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of UBD mRNA | increases expression | 18180321
|
C032036 |
bromobenzene |
bromobenzene results in decreased expression of UBD mRNA | decreases expression | 15056800
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of UBD mRNA | increases expression | 17720352
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of UBD mRNA | increases expression | 15331540
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of UBD mRNA | increases expression | 20106945
|
D003997 |
Dicarbethoxydihydrocollidine |
Dicarbethoxydihydrocollidine results in increased expression of UBD mRNA | increases expression | 18098314
|
D003997 |
Dicarbethoxydihydrocollidine |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of UBD mRNA] | decreases reaction|increases expression | 18098314
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of UBD mRNA | increases expression | 18506893
|
D004052 |
Diethylnitrosamine |
XRCC6 protein inhibits the reaction [Diethylnitrosamine results in increased expression of UBD mRNA] | decreases reaction|increases expression | 18506893
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBD mRNA | affects cotreatment|increases expression | 18164116
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in decreased expression of UBD mRNA | decreases expression | 17547211
|
D004958 |
Estradiol |
Estradiol results in increased expression of UBD mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of UBD mRNA | affects cotreatment|decreases expression | 17404688
|
C533894 |
LG 100815 |
LG 100815 results in increased expression of UBD mRNA | increases expression | 16951191
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of UBD mRNA | increases expression | 16780908
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of UBD mRNA | increases expression | 17616710
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of UBD mRNA | increases expression | 16951191
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of UBD mRNA | increases expression | 16221955
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of UBD mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of UBD mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of UBD mRNA | decreases expression | 17426115
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of UBD mRNA | affects cotreatment|decreases expression | 17404688
|
C045950 |
propiconazole |
propiconazole results in increased expression of UBD mRNA | increases expression | 19363144
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of UBD mRNA | increases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of UBD mRNA | increases expression | 16951191
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of UBD mRNA | increases expression | 17982090
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.59 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.59 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
8.49 | 16100012 12718980 19131640 11954676 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.49 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.83 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
6.83 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.83 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
15.03 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
15.03 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
15.03 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
15.03 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
23.12 | 16434500 17162532 19052882 17620307 18056438 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
23.12 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
23.12 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
23.12 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.45 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.87 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.39 | 15014928 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.95 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
S-Adenosylmethionine |
3.66 | 19056591 16917939 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.20 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.17 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.17 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.17 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.67 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.62 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.62 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
5.62 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
5.62 | 17388661 15093573 15136595 18234424 17020986 11325840 16978400 18323546 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.62 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.62 | 14630087 16675129 18497071 12948864 17261762 17289903 17018787 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.62 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.62 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.62 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.38 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
7.81 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.81 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.95 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| 19363144 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.93 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
10.93 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
10.93 | 20432363 17761372 18691550 3084413 18494052 21159647 10672840 18210153 20101231 19394651 18665156 20084675 19208518 11831363 19418558 20514400 17162532 17138121 17055752 20214788 10737359 16935385 19107877 16288022 16830150 20935162 18056438 18506893 20512989 19519916 16540662 17978847 16698587 19052882 18978308 20727157 19919837 16779866 16681979 18785209 18971187 16502159 19383236 16569478 18393292 16328049 19335982 16878318 19171122 18788625 19822196 16807293 20524982 20007298 19701751 17173139 19539802 3581430 17428255 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
10.93 | 20935162 1701930 6705139 20007298 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.93 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.78 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.68 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.44 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.22 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
7.22 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.22 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.97 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.33 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.33 | 21159647 7505956 2727394 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.33 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.04 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.38 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.74 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.74 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.25 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.25 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.95 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.47 | 12621046 16354765 15340226 8697196 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.47 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.09 | 17035595 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
9.09 | 16867261 17991707 18200517 11698051 17936198 18023891 16782535 16474422 16804969 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.37 | 17276891 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.38 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.38 | 9664655 9142499 10589399 9224671 9125849 16925845 14991402 9211117 17551590 8800419 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.77 | 16989017 18372110 18433785 16413132 11948286 15276878 17979934 10498854 18710439 18093676 18295254 16614059 12913760 12388444 18483878 16651033 15643279 12161096 10700343 17010015 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.48 | 16780908 16823706 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.33 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.90 | 15331540 10990075 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.16 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.04 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.04 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.24 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
8.53 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.53 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
8.53 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.53 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.61 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.81 | 1851702 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.37 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.37 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.37 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.23 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.23 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.58 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.96 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.96 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.32 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.32 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.01 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.90 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.66 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.78 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.37 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.04 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.81 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.90 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.06 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
7.06 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
7.06 | 15623463 16805852 15264214 15547733 16704527 15150132 15547721 16510608 15878914 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.32 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.32 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.95 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
11.95 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.95 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.47 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.47 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.47 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
19.47 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.87 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.30 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.83 | 15172196 16376943 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.05 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.95 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.46 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.46 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.46 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.41 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.08 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.32 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
24.94 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
24.94 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
24.94 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
24.94 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
24.94 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.61 | 17606976 16135485 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.54 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.50 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.50 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.36 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.00 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.68 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.68 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.12 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.48 | 16517039 7193160 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.09 | 18785209 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
11.09 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
11.09 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.09 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.49 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.53 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.53 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.53 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
9.30 | 17994277 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
9.30 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.30 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.54 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.54 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.71 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.71 | 15610895 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.24 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.24 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.41 | 17008537 17802794 18172266 17658394 17296974 18587576 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.93 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.51 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.04 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.02 | 17361223 12679006 17301526 16766008 16935935 19029980 17649720 16140955 16823087 9834237 17294898 16331271 16891316 17368321 19075265 15748426 16788101 17339181 19225113 17217047 19035177 19642359 17712046 17107899 17506722 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.75 | 11830472 10052129 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.02 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.16 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.26 | 20032147 19638242 18665156 18407596 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.26 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dicarbethoxydihydrocollidine |
10.52 | 16015684 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
10.52 | 15571005 16603200 17198567 12918455 18095165 16570917 15081153 16544323 14643895 16270385 17348192 15298665 17432682 18567088 18672772 15942678 17666798 15504291 16627068 18210741 15864749 17719030 18364076 15138612 15577212 17196135 15383259 16042886 17201889 15723089 15492853 15733078 15763062 18237412 16009107 15366600 17036385 15339415 17724770 18637143 14726149 15099470 14709902 18371158 16169303 15067225 18239293 15086199 15369754 15793283 14568256 17203207 15744066 15161499 12925901 17881167 15798949 17534399 17465448 14659978 15479170 17640959 18629640 15842777 15591649 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.52 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.52 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
S-Adenosylmethionine |
10.52 | 15983038 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.52 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.52 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.37 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.37 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
6.37 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
4.22 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
32.78 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
32.78 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
32.78 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
32.78 | 19812893 18978307 19690152 20101389 19638242 19850985 18644402 15885732 19294768 21167192 20137499 15175105 19427195 19090486 9163691 19642983 19073162 2422723 20583210 19551842 18977376 2862719 12771043 19255062 21047994 21071580 19426721 20118626 19833225 20434301 20492335 19254457 20452335 19996281 16942905 18648771 20405173 20501860 18754104 19256749 10737359 12112319 21278145 19499222 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
32.78 | 3113478 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
32.78 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
32.78 | 8742319 19482888 19812893 15975961 19073162 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
32.78 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
32.78 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
32.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
26.29 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
26.29 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
26.29 | 2563599 19009564 21159647 18775883 17854601 17942915 18282651 19126423 19004024 16267830 16842330 18164116 18308698 18079962 9362446 18093689 19519916 18253720 17174075 19539802 3124819 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
26.29 | 6150874 15603536 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
26.29 | 1399818 6150874 18308698 2563599 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
26.29 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.29 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.31 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.31 | 18569708 20064080 6695378 18520028 20135361 20464547 18816296 20869020 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.31 | 20512841 21163286 6695378 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
6.31 | 19555203 16061637 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.31 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.69 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.40 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.00 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.62 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.62 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.27 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.92 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.59 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.22 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.03 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.30 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.96 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.06 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.72 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.72 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.26 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.48 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.02 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
11.02 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.02 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.02 | 16594593 16946489 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.11 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
21.77 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
21.77 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.77 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
21.77 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.92 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.53 | 8761367 15176712 16115947 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.17 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.68 | 12837982 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.90 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.13 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.75 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.76 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.50 | 16517039 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.15 | 17016548 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.78 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.49 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.49 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.49 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.48 | 12161096 18093676 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.48 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
11.73 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.73 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.73 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.73 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.01 | 17698068 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
14.25 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
14.25 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
14.25 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.69 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
15.10 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
15.10 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.10 | 11399792 11896295 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.92 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.92 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.13 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.13 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.13 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.13 | 16740699 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.41 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.28 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.58 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.57 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.20 | 16636934 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.90 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.63 | 16636934 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.56 | 11442880 3137016 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.61 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.81 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.81 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.81 | 16467112 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.30 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.07 | 15862959 16503802 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.06 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
6.17 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.17 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
6.17 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
6.17 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.17 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.77 | 16045194 16684133 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.85 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.06 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.06 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.06 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.60 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.10 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.09 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
8.09 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.09 | 14692829 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.49 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.80 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.40 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.85 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.79 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |